Altered Gene Expression Profiling in Endometrium: Evidence for Progesterone Resistance

ABSTRACT

Progesterone plays an important role in regulating multiple events in the uterus. It controls endometrial proliferation and differentiation, which are important for uterine function. Dysregulation of progesterone signaling leads to impaired physiological functions. Indeed, aberrant expression of progesterone-regulated genes in the endometrium has been implicated in several gynecologic disorders, including endometriosis, polycystic ovarian syndrome (PCOS), and endometrial hyperplasia. Although several investigators have analyzed eutopic endometrial expression of progesterone-target genes, the genesis and consequences of progesterone resistance remain unclear. We review evidence for progesterone resistance in endometrium of women with endometriosis, PCOS, and endometrial hyperplasia, and we identify possible mechanisms associated with reduced progesterone activity in endometrium of (some) women with these gynecologic disorders that have a significant impact on women's health and well-being.

KEYWORDS

Endometriosis - progesterone resistance - cAMP

REFERENCES

• 1 Tabibzadeh S. Molecular control of the implantation window.  Hum Reprod Update. 1998;  4(5) 465-471
• 2 Giudice L C. Endometrium in PCOS: implantation and predisposition to endocrine CA.  Best Pract Res Clin Endocrinol Metab. 2006;  20(2) 235-244
• 3 Talbi S, Hamilton A E, Vo K C et al.. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women.  Endocrinology. 2006;  147(3) 1097-1121
• 4 Giudice L C. Potential biochemical markers of uterine receptivity.  Hum Reprod. 1999;  14(Suppl 2) 3-16
• 5 Lessey B A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception.  Steroids. 2003;  68(10-13) 809-815
• 6 Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair.  J Endocrinol. 2003;  178(3) 357-372
• 7 Aghajanova L, Hamilton A, Kwintkiewicz J, Vo K C, Giudice L C. Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis.  Biol Reprod. 2009;  80(1) 105-114
• 8 Gellersen B, Brosens I A, Brosens J J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives.  Semin Reprod Med. 2007;  25(6) 445-453
• 9 Giudice L C, Kao L C. Endometriosis.  Lancet. 2004;  364(9447) 1789-1799
• 10 Sampson J A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissues into the peritoneal cavity.  Am J Obstet Gynecol. 1927;  14 422-469
• 11 Eskenazi B, Warner M L. Epidemiology of endometriosis.  Obstet Gynecol Clin North Am. 1997;  24(2) 235-258
• 12 Ryan I P, Taylor R N. Endometriosis and infertility: new concepts.  Obstet Gynecol Surv. 1997;  52(6) 365-371
• 13 Giudice L C, Telles T L, Lobo S, Kao L. The molecular basis for implantation failure in endometriosis: on the road to discovery.  Ann N Y Acad Sci. 2002;  955 252-264 discussion 293-255 396-406
• 14 Kim J J, Taylor H S, Lu Z et al.. Altered expression of HOXA10 in endometriosis: potential role in decidualization.  Mol Hum Reprod. 2007;  13(5) 323-332
• 15 Noble L S, Simpson E R, Johns A, Bulun S E. Aromatase expression in endometriosis.  J Clin Endocrinol Metab. 1996;  81(1) 174-179
• 16 Matsuzaki S, Canis M, Vaurs-Barrière C et al.. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection.  Mol Hum Reprod. 2004;  10(10) 719-728
• 17 Kao L C, Germeyer A, Tulac S et al.. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility.  Endocrinology. 2003;  144(7) 2870-2881
• 18 Matsuzaki S, Canis M, Vaurs-Barrière C, Boespflug-Tanguy O, Dastugue B, Mage G. DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection.  Fertil Steril. 2005;  84(Suppl 2) 1180-1190
• 19 Wu Y, Kajdacsy-Balla A, Strawn E et al.. Transcriptional characterizations of differences between eutopic and ectopic endometrium.  Endocrinology. 2006;  147(1) 232-246
• 20 Mettler L, Salmassi A, Schollmeyer T, Schmutzler A G, Püngel F, Jonat W. Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis).  J Assist Reprod Genet. 2007;  24(6) 249-258
• 21 Eyster K M, Klinkova O, Kennedy V, Hansen K A. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium.  Fertil Steril. 2007;  88(6) 1505-1533
• 22 Burney R O, Talbi S, Hamilton A E et al.. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.  Endocrinology. 2007;  148(8) 3814-3826
• 23 Sherwin J R, Sharkey A M, Mihalyi A, Simsa P, Catalano R D, D'Hooghe T M. Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis.  Hum Reprod. 2008;  23(5) 1063-1068
• 24 Lebovic D I, Baldocchi R A, Mueller M D, Taylor R N. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses.  Fertil Steril. 2002;  78(4) 849-854
• 25 Slayden O D, Keator C S. Role of progesterone in nonhuman primate implantation.  Semin Reprod Med. 2007;  25(6) 418-430
• 26 Conneely O M, Maxwell B L, Toft D O, Schrader W T, O'Malley B W. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA.  Biochem Biophys Res Commun. 1987;  149(2) 493-501
• 27 Kastner P, Krust A, Turcotte B et al.. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.  EMBO J. 1990;  9(5) 1603-1614
• 28 Tora L, Gronemeyer H, Turcotte B, Gaub M P, Chambon P. The N-terminal region of the chicken progesterone receptor specifies target gene activation.  Nature. 1988;  333(6169) 185-188
• 29 Vegeto E, Shahbaz M M, Wen D X, Goldman M E, O'Malley B W, McDonnell D P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.  Mol Endocrinol. 1993;  7(10) 1244-1255
• 30 Mulac-Jericevic B, Mullinax R A, DeMayo F J, Lydon J P, Conneely O M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform.  Science. 2000;  289(5485) 1751-1754
• 31 Conneely O M, Mulac-Jericevic B, DeMayo F, Lydon J P, O'Malley B W. Reproductive functions of progesterone receptors.  Recent Prog Horm Res. 2002;  57 339-355
• 32 Nisolle M, Casanas-Roux F, Wyns C, de Menten Y, Mathieu P E, Donnez J. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: a new quantitative method.  Fertil Steril. 1994;  62(4) 751-759
• 33 Prentice A, Randall B J, Weddell A et al.. Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium.  Hum Reprod. 1992;  7(9) 1318-1325
• 34 Attia G R, Zeitoun K, Edwards D, Johns A, Carr B R, Bulun S E. Progesterone receptor isoform A but not B is expressed in endometriosis.  J Clin Endocrinol Metab. 2000;  85(8) 2897-2902
• 35 Bergqvist A, Fernö M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages.  Hum Reprod. 1993;  8(12) 2211-2217
• 36 Bergqvist A, Fernö M. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence.  Fertil Steril. 1993;  60(1) 63-68
• 37 Jänne O, Kauppila A, Kokko E, Lantto T, Rönnberg L, Vihko R. Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue.  Am J Obstet Gynecol. 1981;  141(5) 562-566
• 38 Lyndrup J, Thorpe S, Glenthøj A, Obel E, Sele V. Altered progesterone/estrogen receptor ratios in endometriosis. A comparative study of steroid receptors and morphology in endometriosis and endometrium.  Acta Obstet Gynecol Scand. 1987;  66(7) 625-629
• 39 Lessey B A, Metzger D A, Haney A F, McCarty Jr K S. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy.  Fertil Steril. 1989;  51(3) 409-415
• 40 Wu Y, Strawn E, Basir Z, Halverson G, Guo S W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis.  Epigenetics. 2006;  1(2) 106-111
• 41 Aghajanova L, Velarde M C, Giudice L C. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis.  Endocrinology. 2009;  150(8) 3863-3870
• 42 Gentilini D, Vigano P, Carmignani L, Spinelli M, Busacca M, Di Blasio A M. Progesterone receptor + 331G/A polymorphism in endometriosis and deep-infiltrating endometriosis.  Fertil Steril. 2008;  90(4) 1243-1245
• 43 van Kaam K J, Romano A, Schouten J P, Dunselman G A, Groothuis P G. Progesterone receptor polymorphism+331G/A is associated with a decreased risk of deep infiltrating endometriosis.  Hum Reprod. 2007;  22(1) 129-135
• 44 Klemmt P A, Carver J G, Kennedy S H, Koninckx P R, Mardon H J. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity.  Fertil Steril. 2006;  85(3) 564-572
• 45 Brar A K, Handwerger S, Kessler C A, Aronow B J. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization.  Physiol Genomics. 2001;  7(2) 135-148
• 46 Buzzio O L, Lu Z, Miller C D, Unterman T G, Kim J J. FOXO1A differentially regulates genes of decidualization.  Endocrinology. 2006;  147(8) 3870-3876
• 47 Lee B, Du H, Taylor H S. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium.  Biol Reprod. 2009;  80(1) 79-85
• 48 Fazleabas A T, Brudney A, Chai D, Langoi D, Bulun S E. Steroid receptor and aromatase expression in baboon endometriotic lesions.  Fertil Steril. 2003;  80(Suppl 2) 820-827
• 49 Jackson K S, Brudney A, Hastings J M, Mavrogianis P A, Kim J J, Fazleabas A T. The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity.  Reprod Sci. 2007;  14(2) 137-150
• 50 Hirota Y, Tranguch S, Daikoku T et al.. Deficiency of immunophilin FKBP52 promotes endometriosis.  Am J Pathol. 2008;  173(6) 1747-1757
• 51 Telimaa S, Puolakka J, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.  Gynecol Endocrinol. 1987;  1(1) 13-23
• 52 Telimaa S, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery.  Gynecol Endocrinol. 1987;  1(4) 363-371
• 53 Fedele L, Arcaini L, Bianchi S, Baglioni A, Vercellini P. Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis.  Obstet Gynecol. 1989;  73(6) 1000-1004
• 54 Pal L, Shifren J L, Isaacson K B, Chang Y, Leykin L, Toth T L. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.  J Assist Reprod Genet. 1998;  15(1) 27-31
• 55 Tummon I S, Colwell K A, Mackinnon C J, Nisker J A, Yuzpe A A. Abbreviated endometriosis-associated infertility correlates with in vitro fertilization success.  J In Vitro Fert Embryo Transf. 1991;  8(3) 149-153
• 56 Geber S, Paraschos T, Atkinson G, Margara R, Winston R M. Results of IVF in patients with endometriosis: the severity of the disease does not affect outcome, or the incidence of miscarriage.  Hum Reprod. 1995;  10(6) 1507-1511
• 57 Pellicer A, Oliveira N, Ruiz A, Remohí J, Simón C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction.  Hum Reprod. 1995;  10(Suppl 2) 91-97
• 58 Apridonidze T, Essah P A, Iuorno M J, Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2005;  90(4) 1929-1935
• 59 Essah P A, Nestler J E. Metabolic syndrome in women with polycystic ovary syndrome.  Fertil Steril. 2006;  86(Suppl 1) S18-S19
• 60 Qiao J, Wang L, Li R, Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome.  Reprod Biomed Online. 2008;  17(3) 425-435
• 61 Savaris R, Groll J M, Young S L et al.. Insulin and progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. Paper presented at: 24th Annual Meeting of the European Society of Human Reproduction and Embryology 2008 Barcelona, Spain;
• 62 Gambrell Jr R D, Bagnell C A, Greenblatt R B. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.  Am J Obstet Gynecol. 1983;  146(6) 696-707
• 63 Montgomery B E, Daum G S, Dunton C J. Endometrial hyperplasia: a review.  Obstet Gynecol Surv. 2004;  59(5) 368-378
• 64 Mencaglia L, Valle R F, Perino A, Gilardi G. Endometrial carcinoma and its precursors: early detection and treatment.  Int J Gynaecol Obstet. 1990;  31(2) 107-116
• 65 Linkov F, Edwards R, Balk J et al.. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors.  Eur J Cancer. 2008;  44(12) 1632-1644
• 66 Pérez-Medina T, Bajo J, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.  Gynecol Oncol. 1999;  73(2) 299-304
• 67 Podczaski E, Kaminski P, Gurski K et al.. Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgery.  Gynecol Oncol. 1992;  47(3) 323-327
• 68 Normanno N, Di Maio M, De Maio E NCI-Naple Breast Cancer Group et al. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.  Endocr Relat Cancer. 2005;  12(4) 721-747
• 69 Zupi E, Sbracia M, Marconi D et al.. TNFalpha expression in hyperplastic endometrium.  Am J Reprod Immunol. 2000;  44(3) 153-159
• 70 Zhao S, Chen X, Lu X, Yu Y, Feng Y. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.  Gynecol Oncol. 2007;  105(1) 45-54
• 71 Shen Z Q, Zhu H T, Lin J F. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.  Obstet Gynecol. 2008;  112(2 Pt 2) 465-467
• 72 Amezcua C A, Zheng W, Muderspach L I, Felix J C. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.  Gynecol Oncol. 1999;  73(1) 126-136
• 73 Wang S, Pudney J, Song J, Mor G, Schwartz P E, Zheng W. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia—precursor of endometrial cancer.  Gynecol Oncol. 2003;  88(2) 108-117
• 74 Amezcua C A, Lu J J, Felix J C, Stanczyk F Z, Zheng W. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.  Gynecol Oncol. 2000;  79(2) 169-176
• 75 Chen X, Zhang Z, Feng Y et al.. Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance.  Mod Pathol. 2009;  22(5) 699-708
• 76 Huang G S, Arend R C, Li M et al.. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.  Am J Obstet Gynecol. 2009;  200(4) 451-455